Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 3
2009 8
2010 9
2011 15
2012 11
2013 16
2014 26
2015 16
2016 18
2017 28
2018 33
2019 41
2020 49
2021 60
2022 72
2023 57
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.
LaCasce AS, Bociek RG, Sawas A, Caimi P, Agura E, Matous J, Ansell SM, Crosswell HE, Islas-Ohlmayer M, Behler C, Cheung E, Forero-Torres A, Vose J, O'Connor OA, Josephson N, Wang Y, Advani R. LaCasce AS, et al. Among authors: wang y. Blood. 2018 Jul 5;132(1):40-48. doi: 10.1182/blood-2017-11-815183. Epub 2018 Apr 27. Blood. 2018. PMID: 29703778 Free PMC article. Clinical Trial.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group. Prince HM, et al. Among authors: wang y. Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7. Lancet. 2017. PMID: 28600132
Amyloid and immune homeostasis.
Wang YH, Zhang YG. Wang YH, et al. Immunobiology. 2018 Mar;223(3):288-293. doi: 10.1016/j.imbio.2017.10.038. Epub 2017 Oct 16. Immunobiology. 2018. PMID: 29070439 Review.
Colorectal cancer therapy mediated by nanomedicines.
Zhang S, Zhang H, Song P, Wang D, Wang Y. Zhang S, et al. Among authors: wang y. Chem Commun (Camb). 2023 Apr 11;59(30):4423-4435. doi: 10.1039/d2cc06212g. Chem Commun (Camb). 2023. PMID: 36950975 Review.
Kidney and innate immunity.
Wang YH, Zhang YG. Wang YH, et al. Immunol Lett. 2017 Mar;183:73-78. doi: 10.1016/j.imlet.2017.01.011. Epub 2017 Jan 28. Immunol Lett. 2017. PMID: 28143791 Review.
Forensic Entomology in China and Its Challenges.
Wang Y, Wang Y, Wang M, Xu W, Zhang Y, Wang J. Wang Y, et al. Insects. 2021 Mar 8;12(3):230. doi: 10.3390/insects12030230. Insects. 2021. PMID: 33800343 Free PMC article. Review.
Cancer therapeutic strategies based on metal ions.
Liu Y, Wang Y, Song S, Zhang H. Liu Y, et al. Among authors: wang y. Chem Sci. 2021 Sep 2;12(37):12234-12247. doi: 10.1039/d1sc03516a. eCollection 2021 Sep 29. Chem Sci. 2021. PMID: 34603654 Free PMC article. Review.
421 results